Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Immune cells affect hair growth and could lead to new hair loss treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

IGF-1 affects hair loss and could be a potential treatment.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Ozone therapy might improve cancer treatment and reduce its side effects.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Non-immune factors play a significant role in alopecia areata.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.